These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36931097)

  • 1. Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease.
    Ma X; Wang Q; Liu C; Liu J; Luo G; He L; Yuan T; He RR; Yao Z
    Phytomedicine; 2023 Jun; 114():154749. PubMed ID: 36931097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dan-Lou tablets reduce inflammatory response by inhibiting the activation of NLRP3 inflammasome for coronary heart disease.
    Gao S; He Y; Liu Y; Yu L; Cheng Q; Wang S; Li L; Cui Y; Yu C; Li Z
    Phytomedicine; 2024 Aug; 131():155773. PubMed ID: 38833946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigating phospholipid peroxidation of macrophages in stress-induced tumor microenvironment by natural ALOX15/PEBP1 complex inhibitors.
    Luo X; Li DD; Li ZC; Li ZX; Zou DH; Huang F; Wang G; Wang R; Cao YF; Sun WY; Kurihara H; Liang L; Li YF; Jin W; Wu YP; He RR
    Phytomedicine; 2024 Jun; 128():155475. PubMed ID: 38492368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a three-step-based novel strategy integrating DMPK with network pharmacology and bioactivity evaluation for the discovery of Q-markers of traditional Chinese medicine prescriptions: Danlou tablet as an example.
    Wang Q; Chen G; Chen X; Liu Y; Qin Z; Lin P; Shang H; Ye M; He L; Yao Z
    Phytomedicine; 2023 Jan; 108():154511. PubMed ID: 36334388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Danlou tablet inhibits the inflammatory reaction of high-fat diet-induced atherosclerosis in ApoE knockout mice with myocardial ischemia via the NF-κB signaling pathway.
    Gao S; Xue X; Yin J; Gao L; Li Z; Li L; Gao S; Wang S; Liang R; Xu Y; Yu C; Zhu Y
    J Ethnopharmacol; 2020 Dec; 263():113158. PubMed ID: 32745509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory and antioxidative effects of Dan-Lou tablets in the treatment of coronary heart disease revealed by metabolomics integrated with molecular mechanism studies.
    Li Z; Yang L; Liu Y; Xu H; Wang S; Liu Y; Zhao H; Xie J; Gao S; Gao S; Xu Y; Li L; Li Y; Yu C
    J Ethnopharmacol; 2019 Aug; 240():111911. PubMed ID: 31034953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of hepatocyte phospholipid peroxidation signaling by a Chinese patent medicine against psychological stress-induced liver injury.
    Zhou QQ; Wu YP; Liu P; Deng WZ; Lu YH; Gong HB; Lin XM; Sun WY; Wang R; Huang F; Cao YF; Li YF; Kurihara H; Ouyang SH; Liang L; He RR
    Phytomedicine; 2024 Jul; 129():155613. PubMed ID: 38703659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tianma Gouteng granules decreases the susceptibility of Parkinson's disease by inhibiting ALOX15-mediated lipid peroxidation.
    Jiang YN; Guo YZ; Lu DH; Pan MH; Liu HZ; Jiao GL; Bi W; Kurihara H; Li YF; Duan WJ; He RR; Yao XS
    J Ethnopharmacol; 2020 Jun; 256():112824. PubMed ID: 32259664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology analysis and experimental verification of the antithrombotic active compounds of trichosanthis pericarpium (Gualoupi) in treating coronary heart disease.
    Xia KR; Zhang XY; Zhang HQ; Su KL; Shang EX; Xiao QL; Li WW; Guo S; Duan JA; Liu P
    J Ethnopharmacol; 2024 Jul; 329():118158. PubMed ID: 38614263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the pharmacodynamic substances and possible mechanism of Trichosanthis Pericarpium in the treatment of coronary heart disease based on plasma pharmacochemistry, network pharmacology and experimental validation.
    Zhang XY; Xia KR; Wang YN; Liu P; Shang EX; Liu CY; Liu YP; Qu D; Li WW; Duan JA; Chen Y; Zhang HQ
    J Ethnopharmacol; 2024 May; 325():117869. PubMed ID: 38342153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats.
    Zhao Y; Nie S; Yi M; Wu N; Wang W; Zhang Z; Yao Y; Wang D
    J Ethnopharmacol; 2019 Sep; 241():111908. PubMed ID: 31029757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach.
    Yang Y; Su C; Zhang XZ; Li J; Huang SC; Kuang HF; Zhang QY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123712. PubMed ID: 37060624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics integrated with network pharmacology to clarify effective components and mechanism of Wendan decoction for the intervention of coronary heart disease.
    Lin P; Hu L; Huang Q; Zhang Y; Qin Z; Chen J; Yao X; Wu H; Yao Z; Xu D
    J Ethnopharmacol; 2023 Oct; 314():116669. PubMed ID: 37217155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Integrated strategy for biomarkers of stable coronary heart disease with phlegm and blood stasis syndrome based on RNA-seq and network pharmacology].
    Yang G; Zhou SY; Wang J; Hu J; Pan JH
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1908-1915. PubMed ID: 37282967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational and functional study elicits the ameliorating effect of the Chinese herbal formula Huo Luo Xiao Ling Dan on experimental ischemia-induced myocardial injury in rats via inhibition of apoptosis.
    Han XD; Zhou ZW; Yang W; Ye HC; Xu YZ; Huang YF; Zhang T; Zhou SF
    Drug Des Devel Ther; 2015; 9():1063-102. PubMed ID: 25733819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
    Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
    Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network pharmacology integrated pharmacokinetics strategy for uncovering pharmacological mechanism of compounds absorbed into the blood of Dan-Lou tablet on coronary heart disease.
    Ding M; Ma W; Wang X; Chen S; Zou S; Wei J; Yang Y; Li J; Yang X; Wang H; Li Y; Wang Q; Mao H; Gao XM; Chang YX
    J Ethnopharmacol; 2019 Oct; 242():112055. PubMed ID: 31276751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Baihe Decoction in the treatment of coronary heart disease based on network pharmacology and molecular docking.
    Jin Y; Yin X; Li Z; Xu J
    Ann Palliat Med; 2021 Mar; 10(3):3205-3218. PubMed ID: 33849106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease.
    Song L; Zhang D; Guo C; Gu Z; Wang L; Yao YS; Wang H; Zeng Z; Wang W; Yang Y; Bei W; Rong X; Guo J
    Biomed Pharmacother; 2021 May; 137():111343. PubMed ID: 33761594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma metabolomics-based reveals the treatment mechanism of ShenGui capsule for application to coronary heart disease in a rat model.
    Wang D; Guo J; Liu T; Zhou X; Yang Z; Shi C; Wang W; Li R; Zhang Y; Junzhang ; Yan J; Zhu X; Li Y; Gong M; Cui Y; Wu X
    Anal Biochem; 2022 Apr; 642():114480. PubMed ID: 34813769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.